Wellington Management Group
MRNA icon

Wellington Management Group’s Moderna MRNA Stock Holding History

Wellington Management Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172M Buy
2,461,574
+103,977
+4% +$5.38M 0.03% 416
2026
Q1 		$120M Buy
2,357,597
+2,274,302
+2,730% +$106M 0.02% 503
2025
Q4 		$2.46M Sell
83,295
-3,252
-4% -$88.4K ﹤0.01% 1548
2025
Q3 		$2.24M Buy
86,547
+47,742
+123% +$1.33M ﹤0.01% 1604
2025
Q2 		$1.07M Sell
38,805
-2,856,750
-99% -$75.2M ﹤0.01% 1710
2025
Q1 		$82.1M Sell
2,895,555
-1,019,537
-26% -$36.2M 0.02% 557
2024
Q4 		$163M Sell
3,915,092
-1,309,593
-25% -$62.6M 0.03% 419
2024
Q3 		$349M Buy
5,224,685
+906,114
+21% +$83.2M 0.06% 269
2024
Q2 		$513M Sell
4,318,571
-1,286,132
-23% -$163M 0.09% 206
2024
Q1 		$597M Sell
5,604,703
-1,620,876
-22% -$163M 0.11% 193
2023
Q4 		$719M Buy
7,225,579
+1,614,460
+29% +$136M 0.13% 168
2023
Q3 		$580M Buy
5,611,119
+476,201
+9% +$53.1M 0.12% 177
2023
Q2 		$624M Buy
5,134,918
+842,683
+20% +$112M 0.12% 174
2023
Q1 		$659M Buy
4,292,235
+15,271
+0.4% +$2.52M 0.13% 164
2022
Q4 		$768M Sell
4,276,964
-434,137
-9% -$71M 0.15% 146
2022
Q3 		$557M Buy
4,711,101
+339,752
+8% +$51.6M 0.12% 178
2022
Q2 		$624M Buy
4,371,349
+4,067,828
+1,340% +$581M 0.13% 160
2022
Q1 		$52.3M Sell
303,521
-115,369
-28% -$19.4M 0.01% 744
2021
Q4 		$106M Buy
418,890
+375,776
+872% +$110M 0.02% 611
2021
Q3 		$16.6M Sell
43,114
-107,294
-71% -$39.6M ﹤0.01% 1129
2021
Q2 		$35.3M Buy
150,408
+129,090
+606% +$23.1M 0.01% 942
2021
Q1 		$2.79M Buy
21,318
+8,739
+69% +$1.27M ﹤0.01% 1556
2020
Q4 		$1.31M Sell
12,579
-15,511
-55% -$1.57M ﹤0.01% 1570
2020
Q3 		$1.99M Buy
+28,090
New +$1.96M ﹤0.01% 1411
2019
Q4 		– Sell
-399,454
Closed -$6.36M – 2070
2019
Q3 		$6.36M Sell
399,454
-1,439,884
-78% -$21.3M ﹤0.01% 1282
2019
Q2 		$26.9M Sell
1,839,338
-1,213,338
-40% -$26.1M 0.01% 938
2019
Q1 		$62.1M Sell
3,052,676
-155
-0% -$2.88K 0.01% 680
2018
Q4 		$46.6M Buy
+3,052,831
New +$50.2M 0.01% 727

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Wellington Management Group's MRNA Position: Q2 2026 in Review

Wellington Management Group increased its Moderna (MRNA) stake by 4.4% in Q2 2026, buying an estimated $5.38M and bringing the position to 2,461,574 shares worth $172M. The position accounts for 0.03% of the portfolio, ranked #416.

Wellington Management Group first reported a position in MRNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $768M in Q4 2022. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Wellington Management Group held 2,461,574 shares of Moderna worth $172M as of Q2 2026.
  • Wellington Management Group bought 103,977 Moderna shares in Q2 2026, an estimated $5.38M.
  • Moderna made up 0.03% of Wellington Management Group's portfolio in Q2 2026, its #416 holding.
  • Wellington Management Group first reported a position in Moderna in Q4 2018 and has held it in 28 quarters since.
  • Wellington Management Group's Moderna position peaked at $768M in Q4 2022.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.